Venezuela uses distressed bonds to settle debts with drugmakers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Fiserv president resigns, interim leaders named for financial unit
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Jefferies Cuts Price Target on Pfizer (PFE) to $42; Reiterates Buy
March 8, 2016 8:41 AM ESTJefferies maintained a Buy rating on Pfizer (NYSE: PFE), and cut the price target to $42.00 (from $45.00). Jefferies updated their model following the Form S-4 filing for certain LOE assumptions, as well as some fine-tuning on stand-alone operating costs and tax rate assumptions in the... More
